We are live on ! Find out more
ACM

AH Capital Management Portfolio holdings

AUM $1.29B
1-Year Est. Return 26.81%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
-26.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$185M
Cap. Flow
+$290M
Cap. Flow %
18.34%
Top 10 Hldgs %
99.26%
Holding
13
New
2
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
NAVN
Navan Inc
NAVN
+$432M
2
HTBK
Heritage Commerce
HTBK
+$898K

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$120M
2
OMDA
Omada Health Inc
OMDA
+$23.4M

Sector Composition

Rank Sector Weight
1 Technology 72.02%
2 Healthcare 19.09%
3 Communication Services 8.88%
4 Financials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIG
1
Figma
FIG
$12B
$607M 38.43%
16,246,129
– –
NAVN
2
Navan Inc
NAVN
$6.36B
$464M 29.4%
+27,195,364
New +$432M
META icon
3
Meta Platforms (Facebook)
META
$1.52T
$140M 8.88%
212,531
– –
RVMD icon
4
Revolution Medicines
RVMD
$40B
$73.4M 4.64%
921,099
-1,827,424
-66% -$120M
MAZE
5
Maze Therapeutics
MAZE
$1.58B
$70.5M 4.46%
1,702,225
– –
XYZ
6
Block Inc
XYZ
$47.6B
$66.2M 4.19%
1,016,697
– –
OMDA
7
Omada Health Inc
OMDA
$1.22B
$54.6M 3.46%
3,460,929
-1,153,645
-25% -$23.4M
BIOA
8
BioAge Labs
BIOA
$970M
$44.1M 2.79%
3,233,170
– –
NAUT icon
9
Nautilus Biotechnolgy
NAUT
$213M
$34.4M 2.18%
17,653,917
– –
CAMP icon
10
CAMP4 Therapeutics
CAMP
$181M
$13M 0.82%
2,125,339
– –
ERAS icon
11
Erasca
ERAS
$6.68B
$10.6M 0.67%
2,862,500
– –
DNA icon
12
Ginkgo Bioworks
DNA
$486M
$902K 0.06%
108,568
– –
HTBK
13
DELISTED
Heritage Commerce
HTBK
$129K 0.01%
+82,740
New +$898K

Similar funds

PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
ACM
Alta Capital Management Salt Lake City, Utah $1.29B AUM 17.57% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
MA
MONECO Advisors Fairfield, Connecticut $1.29B AUM 18.01% 1-Year Est. Return
CTA
Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return

AH Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, AH Capital Management held 13 positions worth $1.58B, up 13% from $1.39B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

AH Capital Management deployed $290M of net new capital in Q4 2025, opening 2 new positions. Its largest new stake was Navan Inc: 27,195,364 shares worth $464M.

By sector, the portfolio is most concentrated in Technology at 72% of assets, up from 66% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Revolution Medicines, an estimated $120M trimmed.

  • AH Capital Management's largest Q4 2025 buy was Navan Inc: 27,195,364 shares worth $464M.
  • AH Capital Management's biggest Q4 2025 reduction was Revolution Medicines, cutting an estimated $120M.
  • AH Capital Management's ten largest holdings make up 99% of its $1.58B portfolio in Q4 2025.
  • AH Capital Management opened 2 new positions and closed 0 in Q4 2025.
  • AH Capital Management's portfolio value rose 13% quarter-over-quarter to $1.58B.

Based on AH Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.